Company news

Quanterix Corporation news in 2020

Quanterix Corporation's news releases, calls and decks from 2020, newest first.

View company

Quanterix Receives FDA Emergency Use Authorization for Semi-Quantitative Antibody Test

December 27, 2020

Quanterix Appoints William Geist as Chief Operating Officer

November 17, 2020

Quanterix Corporation Releases Operating Results for Third Quarter 2020

November 4, 2020

Quanterix Corporation to Release Third Quarter 2020 Financial Results on November 5, 2020

October 28, 2020

Quanterix Receives National Institutes of Health RADx Contract to Advance Antigen Test for SARS-CoV-2 (COVID-19)

October 5, 2020

Quanterix Announces Closing of Public Offering Including Exercise in Full of Underwriters’ Option to Purchase Additional Shares

August 10, 2020

Quanterix Prices Public Offering of Common Stock

August 5, 2020

Quanterix Announces Proposed Public Offering of Common Stock

August 5, 2020

Quanterix Corporation Releases Operating Results for Second Quarter 2020

August 3, 2020

Quanterix Expands Menu of Ultra-Sensitive Neurology Assays with Simoa® P-Tau181 V2 Kit for Improved Detection and Study of Alzheimer’s Disease

May 28, 2020

Quanterix Corporation Releases Operating Results for First Quarter 2020

May 4, 2020

Quanterix Announces Simoa® Success Grant Program to Accelerate Promising Infectious Disease & Immunology Research

April 23, 2020

Quanterix Corporation Releases Operating Results for Fourth Quarter and Full Year 2019

March 8, 2020

Calls in 2020

Decks in 2020